Resmed
ResMed is rated a buy, with the stop-loss at $27.81

ResMed is rated a buy, with the stop-loss at $27.81

ResMed add to watchlist and wait for a close above the 10-day average.

ResMed is due to report 4Q23E EPS Friday.

ResMed is due to report 4Q23E EPS Friday.

ResMed is under Algo Engine buy conditions.
